GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

ZSA-215   Click here for help

GtoPdb Ligand ID: 13969

Synonyms: compound 2dr [PMID: 40442142] | ZSA215
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: ZSA-215 is an orally bioavailable, non-cyclic dinucleotide STING agonist [1]. It was designed as cancer immunotherapy.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 110.16
Molecular weight 327.33
XLogP 0.36
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COC1=CC2=C(C=C1OC)SC(=C2F)C(=O)NCCC(=O)O
Isomeric SMILES O=C(O)CCNC(C1=C(F)C2=CC(OC)=C(OC)C=C2S1)=O
InChI InChI=1S/C14H14FNO5S/c1-20-8-5-7-10(6-9(8)21-2)22-13(12(7)15)14(19)16-4-3-11(17)18/h5-6H,3-4H2,1-2H3,(H,16,19)(H,17,18)
InChI Key KJLZKQLYGGJWHO-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Immunopharmacology Comments
Designed to activate the cGAS-STING pathway as a novel cancer immunotherapy agent. This mechanism is exploited to initiate innate immunity against cancer cells.